Literature DB >> 17096372

Validity of the Center for Epidemiologic Studies Depression Scale as a screening instrument of major depressive disorder among Japanese workers.

Koji Wada1, Katsutoshi Tanaka, Gilles Theriault, Toshihiko Satoh, Masaru Mimura, Hitoshi Miyaoka, Yoshiharu Aizawa.   

Abstract

BACKGROUND: The Center for Epidemiologic Studies Depression Scale (CES-D) is used at workplaces to screen depressive disorders. The aim of this study was to examine the validity of the CES-D for depression in a workplace.
METHODS: The CES-D was administered to 2,219 workers (84.2% men; age 21-68 years) at a manufacturing company in Japan. Concomitantly all workers had an interview with the Mini International Neuropsychiatric Interview (MINI) as a gold standard for diagnosing major depressive disorder (MDD). The validity was evaluated by a receiver operating characteristic (ROC) curve.
RESULTS: The area under the ROC curve of the CES-D was 0.96 [95% Confidence Interval (CI): 0.94-0.99]. The optimal cut-off score of MDD was 19 for screening.
CONCLUSIONS: The validity of CES-D is confirmed and it is a valid instrument for detecting MDD in working populations in Japan. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17096372     DOI: 10.1002/ajim.20403

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  37 in total

1.  Taking it like a man: masculine role norms as moderators of the racial discrimination-depressive symptoms association among African American men.

Authors:  Wizdom Powell Hammond
Journal:  Am J Public Health       Date:  2012-03-08       Impact factor: 9.308

2.  Association between epigenetic age acceleration and depressive symptoms in a prospective cohort study of urban-dwelling adults.

Authors:  May A Beydoun; Sharmin Hossain; Kumaraswamy Naidu Chitrala; Salman M Tajuddin; Hind A Beydoun; Michele K Evans; Alan B Zonderman
Journal:  J Affect Disord       Date:  2019-06-30       Impact factor: 4.839

3.  Patient-Reported Outcome Measures in Registry-Based Studies of Type 2 Diabetes Mellitus: a Systematic Review.

Authors:  Yu Ting Chen; Yan Zhi Tan; Mcvin Cheen; Hwee-Lin Wee
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

4.  Effort-reward imbalance and depression among private practice physicians.

Authors:  Akizumi Tsutsumi; Shoko Kawanami; Seichi Horie
Journal:  Int Arch Occup Environ Health       Date:  2011-06-08       Impact factor: 3.015

5.  Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients.

Authors:  Hiroyuki Kayano; Shinji Koba; Taiju Matsui; Hiroto Fukuoka; Kyouichi Kaneko; Makoto Shoji; Tsutomu Toshida; Norikazu Watanabe; Eiichi Geshi; Youichi Kobayashi
Journal:  Hypertens Res       Date:  2015-07-02       Impact factor: 3.872

6.  Inverse association between dietary habits with high total antioxidant capacity and prevalence of frailty among elderly Japanese women: a multicenter cross-sectional study.

Authors:  S Kobayashi; K Asakura; H Suga; S Sasaki
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

7.  Workplace Discrimination and Depressive Symptoms: A Study of Multi-Ethnic Hospital Employees.

Authors:  Wizdom Powell Hammond; Marion Gillen; Irene H Yen
Journal:  Race Soc Probl       Date:  2010-03-01

8.  Challenges in assessing depressive symptoms in Fiji: A psychometric evaluation of the CES-D.

Authors:  April Opoliner; Deborah Blacker; Garrett Fitzmaurice; Anne Becker
Journal:  Int J Soc Psychiatry       Date:  2013-07-22

9.  Prospective study of cardiorespiratory fitness and depressive symptoms in women and men.

Authors:  Xuemei Sui; James N Laditka; Timothy S Church; James W Hardin; Nancy Chase; Keith Davis; Steven N Blair
Journal:  J Psychiatr Res       Date:  2008-10-08       Impact factor: 4.791

10.  Implementation of Internet-based preventive interventions for depression and anxiety: role of support? The design of a randomized controlled trial.

Authors:  Tara Donker; Annemieke van Straten; Heleen Riper; Isaac Marks; Gerhard Andersson; Pim Cuijpers
Journal:  Trials       Date:  2009-07-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.